JPRN-UMIN000026293尚未招募未知
Rituximab for anti-NMDAR encephalitis - Rituximab for anti-NMDAR encephalitis
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 2
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •infant, pregnant woman
研究者
相似试验
进行中（未招募）
3 期
Rituximab in Primary Central Nervous system Lymphoma.A randomized Dutch/Belgian Hemato-Oncology Cooperative Group (HOVON) / Australasian Leukaemia and Lymphoma Group (ALLG) intergroup studyprimary central nervous system (CNS) lymphomaCancer - Lymphoma (non Hodgkin's lymphoma) - High grade lymphomaACTRN12610000908033HOVO45
进行中（未招募）
不适用
Rituximab in Primary Central Nervous system Lymphoma.A randomized HOVON / ALLG intergroup studyEUCTR2009-014722-42-NLHOVON Foundation200
已完成
3 期
Rituximab in Primary Central Nervous system Lymphoma. A randomized HOVON / ALLG intergroup studyPrimary Central Nervous system Lymphoma10025320NL-OMON43562HOVO130
招募中
不适用
Rituximab in Primary Central Nervous system Lymphoma.A randomized HOVON / ALLG intergroup study.Primary Central Nervous System Lymphoma (PCNSL)NL-OMON20855Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON) P/a HOVON Data CenterErasmus MC - Daniel den HoedP.O. box 52013008 AE RotterdamTel: +31 10 7041560Fax: +31 10 7041028e-mail: hdc@erasmusmc.nl200
进行中（未招募）
不适用
Rituximab plus Bendamustine as front line treatment in frail elderly (=70 years) patients with diffuse large B-cell non-Hodgkin’s lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi (FIL)EUCTR2011-001421-24-ITFONDAZIONE ITALIANA LINFOMI ONLUS